About Dr Gary Stiefel
Dr Gary Stiefel has been a Consultant in Paediatric Allergy at the University Hospitals of Leicester NHS Trust since 2012. He is the current lead for the Childrens’ allergy service. It is one of the largest clinics in the UK and offers a comprehensive service.
Gary undertook his medical training at the University of Birmingham and in 2012 completed specialist training in Paediatric Allergy. During his training he worked at both St Mary’s Hospital, London and University Hospital Southampton Foundation Trust and also completed an Allergy MSc at Imperial College London.
Gary was the lead author for the BSACI national guidelines on nut allergy and was involved in
changing the legislation allowing schools to be able to hold generic Adrenaline Autoinjectors alongside Allergy UK and Anaphylaxis UK. In 2020 he led a national British Paediatric Surveillance Unit (BPSU) RCPCH study into FPIES. He is actively involved in peanut desensitisation studies and currently recruiting patients for The Natasha Clinical Trial offering milk and peanut oral immunotherapy.
Gary has previously served as a RCPCH specialist advisory committee members for Allergy, Immunology and Infectious Diseases (2014-2019). He has been a trustee for Allergy UK since 2019 and is the current Health Advisory Board Chair since October 2024.
Gary is actively involved in teaching locally & regionally and regularly lectures on the Allergy MSc at University of Southampton. His interests include food allergy, eczema, allergic rhinitis (including hay fever) and Oral and aeroallergen immunotherapy.
Gary is a member of the BSACI (British Society of Allergy and Clinical Immunology) and the EAACI
(European Academy of Allergy and Clinical Immunology).
Qualifications
MBChB, BMedSci, FRCPCH, MSc Allergy
Website
https://www.childrensallergycambridge.co.uk
Instagram
https://www.instagram.com/garystiefel/
Gary undertook his medical training at the University of Birmingham and in 2012 completed specialist training in Paediatric Allergy. During his training he worked at both St Mary’s Hospital, London and University Hospital Southampton Foundation Trust and also completed an Allergy MSc at Imperial College London.
Gary was the lead author for the BSACI national guidelines on nut allergy and was involved in
changing the legislation allowing schools to be able to hold generic Adrenaline Autoinjectors alongside Allergy UK and Anaphylaxis UK. In 2020 he led a national British Paediatric Surveillance Unit (BPSU) RCPCH study into FPIES. He is actively involved in peanut desensitisation studies and currently recruiting patients for The Natasha Clinical Trial offering milk and peanut oral immunotherapy.
Gary has previously served as a RCPCH specialist advisory committee members for Allergy, Immunology and Infectious Diseases (2014-2019). He has been a trustee for Allergy UK since 2019 and is the current Health Advisory Board Chair since October 2024.
Gary is actively involved in teaching locally & regionally and regularly lectures on the Allergy MSc at University of Southampton. His interests include food allergy, eczema, allergic rhinitis (including hay fever) and Oral and aeroallergen immunotherapy.
Gary is a member of the BSACI (British Society of Allergy and Clinical Immunology) and the EAACI
(European Academy of Allergy and Clinical Immunology).
Qualifications
MBChB, BMedSci, FRCPCH, MSc Allergy
Website
https://www.childrensallergycambridge.co.uk
https://www.instagram.com/garystiefel/
At a glance
25 yrs
Years in practice
171
Verified reviews
1
Languages
99/100
Trust score
Specialties
Paediatrics
Credentials & education
Source: www.doctify.com- BM BMedSci
- FR FRCPCH
- MB MBChB
- MS MSc
- BA BA